TEI 8364

structure in first source

Also Known As:

2-(7-(2-naphthyl)-6-heptenamide)benzoic acid; 2-(7-(2-naphthyl)-6-heptenamido)benzoic acid; TEI-8364

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 08/01/1995 - "Furthermore, TEI-8364 at a dose of 1 mg/mouse/day selectively inhibited IgE production by severe combined immunodeficiency mice engrafted with human PBMC, if the drug was administered subcutaneously for five consecutive days. "

1.	Immunoglobulin E (IgE)